Education
About Us
Working with TipRanks
Follow Us
Collegium Pharmaceutical (COLL)
NASDAQ:COLL
Total Valuation
Collegium Pharmaceutical has a market cap or net worth of $1.34B. The enterprise value is $2.01B.
Market Cap$1.34B
Enterprise Value$2.01B
Share Statistics
Collegium Pharmaceutical has 31,610,975 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding31,610,975
Owned by Insiders13.39%
Owned by Institutions0.87%
Financial Efficiency
Collegium Pharmaceutical’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 9.78%.
Return on Equity (ROE)0.30
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)9.78%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee1.77M
Profits Per Employee193.81K
Employee Count357
Asset Turnover0.38
Inventory Turnover7.15
Valuation Ratios
The current PE Ratio of Collegium Pharmaceutical is 26.3. Collegium Pharmaceutical’s PEG ratio is 0.40.
PE Ratio26.3
PS Ratio1.46
PB Ratio4.04
Price to Fair Value4.04
Price to FCF4.55
Price to Operating Cash Flow4.59
PEG Ratio0.40
Income Statement
In the last 12 months, Collegium Pharmaceutical had revenue of 631.45M and earned 69.19M in profits. Earnings per share was 2.14.
Revenue631.45M
Gross Profit377.34M
Operating Income169.90M
Pretax Income98.57M
Net Income69.19M
EBITDA341.70M
Earnings Per Share (EPS)2.14
Cash Flow
In the last 12 months, operating cash flow was 290.92M and capital expenditures -1.62M, giving a free cash flow of 289.30M billion.
Operating Cash Flow290.92M
Free Cash Flow289.30M
Free Cash Flow per Share9.15
Dividends & Yields
Collegium Pharmaceutical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.35
52-Week Price Change38.59%
50-Day Moving Average35.70
200-Day Moving Average31.79
Relative Strength Index (RSI)79.96
Average Volume (3m)392.25K
Important Dates
Collegium Pharmaceutical upcoming earnings date is Feb 19, 2026, TBA (Confirmed).
Last Earnings DateNov 6, 2025
Next Earnings DateFeb 19, 2026
Ex-Dividend Date―
Financial Position
Collegium Pharmaceutical as a current ratio of 0.95, with Debt / Equity ratio of 296.20%
Current Ratio0.95
Quick Ratio0.88
Debt to Market Cap1.05
Net Debt to EBITDA2.66
Interest Coverage Ratio2.30
Taxes
In the past 12 months, Collegium Pharmaceutical has paid 29.38M in taxes.
Income Tax29.38M
Effective Tax Rate0.30
Enterprise Valuation
Collegium Pharmaceutical EV to EBITDA ratio is 5.37, with an EV/FCF ratio of 9.02.
EV to Sales2.90
EV to EBITDA5.37
EV to Free Cash Flow9.02
EV to Operating Cash Flow8.95
Balance Sheet
Collegium Pharmaceutical has $305.71M in cash and marketable securities with $936.27M in debt, giving a net cash position of -$630.55M billion.
Cash & Marketable Securities$305.71M
Total Debt$936.27M
Net Cash-$630.55M
Net Cash Per Share-$19.95
Tangible Book Value Per Share-$25.56
Margins
Gross margin is 57.22%, with operating margin of 26.91%, and net profit margin of 10.96%.
Gross Margin57.22%
Operating Margin26.91%
Pretax Margin15.61%
Net Profit Margin10.96%
EBITDA Margin54.11%
EBIT Margin27.32%
Analyst Forecast
The average price target for Collegium Pharmaceutical is $45.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$45.50
Price Target Upside4.53% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast26.34%
EPS Growth Forecast-32.79%